Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
Titel:
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
Auteur:
Khairullin, Berik Zakarya, Kunsulu Orynbayev, Mukhit Abduraimov, Yergali Kassenov, Markhabat Sarsenbayeva, Gulbanu Sultankulova, Kulyaisan Chervyakova, Olga Myrzakhmetova, Balzhan Nakhanov, Aziz Nurpeisova, Ainur Zhugunissov, Kuandyk Assanzhanova, Nurika Nurabayev, Sergazy Kerimbayev, Aslan Yershebulov, Zakir Burashev, Yerbol Kulmagambetov, Ilyas Davlyatshin, Timur Sergeeva, Maria Buzitskaya, Zhanna Stukova, Marina Kutumbetov, Lespek